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Abstract
Mice over-expressing the a12subunit (pore) of the L-type Ca
2+ channel (a1CTG) by 4months (mo) of age exhibit an enlarged
heart, hypertrophied myocytes, increased Ca
2+ current and Ca
2+ transient amplitude, but a normal SR Ca
2+ load. With
advancing age (8–11 mo), some mice demonstrate advanced hypertrophy but are not in congestive heart failure (NFTG),
while others evolve to frank dilated congestive heart failure (FTG). We demonstrate that older NFTG myocytes exhibit a
hypercontractile state over a wide range of stimulation frequencies, but maintain a normal SR Ca
2+ load compared to age
matched non-transgenic (NTG) myocytes. However, at high stimulation rates (2–4 Hz) signs of diastolic contractile failure
appear in NFTG cells. The evolution of frank congestive failure in FTG is accompanied by a further increase in heart mass and
myocyte size, and phospholamban and ryanodine receptor protein levels and phosphorylation become reduced. In FTG, the
SR Ca
2+ load increases and Ca
2+ release following excitation, increases further. An enhanced NCX function in FTG, as
reflected by an accelerated relaxation of the caffeine-induced Ca
2+ transient, is insufficient to maintain a normal diastolic
Ca
2+ during high rates of stimulation. Although a high SR Ca
2+ release following excitation is maintained, the
hypercontractile state is not maintained at high rates of stimulation, and signs of both systolic and diastolic contractile
failure appear. Thus, the dilated cardiomyopathy that evolves in this mouse model exhibits signs of both systolic and
diastolic failure, but not a deficient SR Ca
2+ loading or release, as occurs in some other cardiomyopathic models.
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Introduction
Much evidence has accumulated since the first cytosolic Ca
2+
transient measurements in cardiac muscle from heart failure (HF)
patients [1] to support a role for alterations in myocyte ‘‘Ca
2+
handling’’ in the pathophysiology of HF. Although multiple
alterations in various aspects of myocyte excitation-contraction
coupling have been observed in HF, the central mechanism of the
reduced Ca
2+ transient amplitude has been emphasized and has
been attributed to a reduction of sarcoplasmic reticulum (SR) Ca
2+
content [1–7].
Longitudinal assessment of cardiac structure and function in a
novel transgenic mouse that over expresses the a1C-subunit of the
L-type Ca
2+ channel (a1CTG) indicates that like droves of other
‘‘boutique mice’’ (Table S1), this mouse, develops cardiac
hypertrophy, during which adaptive Ca
2+ regulatory mechanisms
are mobilized. The remarkable orchestration among cardiomyo-
cyte Ca
2+ regulatory proteins in this model at 4months (mo) is
instructive because it provides clues with respect to coordinated,
adaptive remodeling of Ca
2+ regulation to maintain a normal SR
Ca
2+ load at 4 mo of age [4]. Specifically, during the hypertrophic,
pre-HF stage, while an L-type current of a larger amplitude
triggers larger Ca
2+ release from the SR to produce a whole cell
Ca
2+ transient of increased amplitude, neither the SR Ca
2+ load,
as assessed by caffeine induced Ca
2+ release, nor diastolic cytosolic
Ca
2+ levels, nor Ca
2+ spark characteristics, are altered [4]. An
overexpression of NCX protein, which enhances Ca
2+ efflux to
balance the enhanced Ca
2+ influx via the overexpressed L-type
Ca
2+ channel prevents excess cytosolic calcium loading [4].
Between 8–11 mo of age, however, the adapted, hypertrophic
heart of the a1CTG mouse maladapts into a dilated, lethal
cardiomyopathy [4]. The hypothesis of the present study is that
adaptations in Ca
2+ regulation observed at a younger age (4 mo) in
NTG cells wane with the evolution of more advanced hypertrophy
and HF that accompany advancing age. Specifically, we
hypothesized that these adaptations become compromised in the
non-failing advanced hypertrophic stage (NFTG), and ‘‘fail’’
outright as the end-stage dilated congestive failure (FTG) evolves.
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Heart and Myocyte Size
Heart weight in FTG was over two-fold greater than in NTG
(Figure 1A). Body weight did not differ between NTG and NFTG
but body weight increased by 15% in FTG, likely as a result of
fluid accumulation (Figure 1B). The heart weight/body weight
increased by 43% in NFTG vs NTG, by 27% in FTG vs. NFTG,
and by 82% in FTG vs NTG (Figure 1C). The average myocyte
size, estimated from cell capacitance, reflected the relative heart
mass. It increased by 25% in NFTG vs NTG, and in FTG further
increased by 29%. Thus, myocyte size in failing FTG averaged
61% more than that in NTG (Figure 1D).
Ca
2+ Current and Electrical Stimulation-Induced Ca
2+
Transients
Peak ICa density in NFTG and FTG was increased compared to
NTG, despite a significant increase in cell capacitance
(293.5615.02 pF, 330.93613.53 pF vs 254.6167.76 pF, respec-
tively). No statistically significant difference was observed between
NFTG and FTG (Figure 2A). Inactivation rate constants of ICaL
are illustrated in Figure 2B. Tau fast did not differ among groups
but Tau slow was prolonged in both TG groups compared to
NTG. In rodent myocytes, the rested state Ca
2+ transient in
Figure 3 is usually the maximal that can be achieved, due to a
maximum SR Ca
2+ load and release achieved during rest. Upon
continued stimulation from rest a typical negative staircase in Ca
2+
transient typically occurs. This reflects, in part, a net reduction in
cell and SR Ca
2+ loading.
The amplitude of the Indo-1 fluorescence transient (peak-rest or
peak-diastolic level) elicited by electrical stimulation declined
sharply between the first stimulation following rest and steady state
stimulation at 0.5 Hz. There was little further decline thereafter as
the stimulation rate was increased (Figure 3B). Following rest, and
at all frequencies of stimulation, the Indo-1 transient amplitude in
FTG was greater than in NTG. In NFTG group, data were
available only at rest and 0.5 Hz. The Indo 1 fluorescent transient
at these two frequencies was intermediate between that of FTG
and NTG.
The maximum rate of rise (VMAX) of the Indo fluorescent
transient (Figure 3C) reports the amplitude of the SR Ca
2+ release
flux with fidelity [1,8,9]. Differences among the three groups in
VMAX upon stimulation from rest were similar to those of the
amplitude of the fluorescence transient. This suggests that the
decline in the Ca
2+ transient amplitude from the post-rest state
reflects a decrease in excitation induced SR Ca
2+ release. A
greater Ca
2+ transient VMAX across the range of stimulation rates
in FTG indicates that the magnitude of excitation-induced SR
release in FTG is greater than in NTG.
Continued stimulation from rest accelerated the decay of the
Ca
2+ transient (Figure 3D). The T50 of relaxation was prolonged in
FTG vs. NTG across the range of stimulation; the difference is
Figure 1. Development of cardiac hypertrophy and heart failure in Cav1.2a1C transgenic mice. (A) Measurement of heart weight, (B)
body weight, (C) heart/body weight ratio and (D) size of myocytes estimated from cell capacitance in Non-Transgenic (NTG), Non-Failing Cav1.2a1C-
Transgenic (NFTG) and Failing Cav1.2a1C-Transgenic (FTG) mouse groups (8–12 mo). n= 9 NTG, 4 NFTG and 4 FTG in (A,B and C) and 26 NTG, 12
NFTG and 31 FTG in (D).
doi:10.1371/journal.pone.0004133.g001
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measured over the limited range of frequencies in NFTG did not
differ from NTG or FTG.
At rest there was no difference in the resting Indo-1 fluorescence
ratio among the three groups of cells (Figure 3E). Upon regular
electrical stimulation from rest the diastolic Indo fluorescence at
rates up to 4 Hz in NTG did not exceed that at rest. In contrast, in
FTG the diastolic fluorescence increases as the stimulation rate
increases, exceeding that at rest by 10% at 4 Hz. Note that the
difference in the resting fluorescence ratio prior to stimulation and
diastolic fluorescence ratio at 4 Hz was about 0.10 (Figure 3E).
The amplitude of fluorescence transient elicited by excitation at
4 Hz was about 0.22 (Figure 3B). Thus, even if only 50% of the
change from the resting Indo fluorescence reports a true change in
diastolic cytosolic Ca
2+, the increase in diastolic Ca
2+ in FTG with
stimulation is substantial. During excitation at 4 Hz, this increase
averaged 20–25% of the Ca
2+ transient amplitude.
Caffeine-Induced Ca
2+ Transients
We assessed the SR Ca
2+ load by a rapid, brief application of
caffeine to the cell. In a prior study, no difference was noted, in the
amplitude of caffeine-induced Indo fluorescent transient between
NTG and a1CTG at 4 mo and 9 mo. Likewise, in the present
study, there was no difference in the amplitude of the caffeine-
induced transient between NFTG and NTG (Figure 4). But the
caffeine-induced transient in FTG was increased compared to
NFTG or NTG groups (Figure 4). Note that the amplitude of the
caffeine transient at 4 Hz did not vary from that at rest, in contrast
to the amplitude of the transient induced by electrical stimulation,
which is much larger at rest than that at 4 Hz (Figure 4A). Thus,
by rough calculations, the SR ‘‘fractional release’’ in response to
electrical stimulation, i.e., the ratio of the electrical stimulation and
caffeine Ca
2+ transients’ amplitudes was reduced at 4 Hz
compared to rest. The extent of this reduction was comparable
in NTG and FTG: at rest it averaged 0.85 and 0.83 respectively,
and at 4 Hz was 0.39 and 0.47, respectively.
Figure 4A, B also shows that the decay rate of the caffeine
transient is accelerated in FTG. This is more clearly illustrated by
normalization of the data during the decay to the peak amplitude
in each cell (Figure 5A and B). On an average, the T50 of
relaxation of the caffeine-induced Indo transient was accelerated
by 50% in FTG vs. NTG (Figure 5C). In NFTG, the T50 did not
differ from that of NTG following rest. During continuous pacing,
however, the T50 in NFTG became less than NTG. The decay of
the caffeine transient following 4 Hz stimulation was slower than
at rest in both NTG and FTG. But FTG T50 still remained
substantially accelerated compared to NTG. NFTG showed no
increase or difference from FTG (Figure 5C). The ability of NFTG
to maintain the same T50 of the caffeine transient following 4 Hz
as at rest suggests that NCX reserve may be greater in NFTG than
in FTG or NTG cells.
A comparison of Figure 5 and Figure 3D reveals that the group
differences between FTG and NTG in the T50 of the caffeine
induced transient decay and the T50 of electrical stimulation
induced transient are reversed: the electrical stimulation induced
transient T50, which largely reflects SR Ca
2+ pumping, was more
rapid in NTG than FTG. The caffeine induced transient T50,
reflecting mostly NCX Ca
2+ extrusion, was more rapid in FTG
than NTG. However, a relative failure of SERCA2a and NCX to
dissipate cytosolic Ca
2+ at high rates of electrical stimulation in
FTG likely explains the failure to regulate the diastolic Indo
fluorescence (Figure 3E).
Figure 2. Electrophysiological effects of Cav1.2a1C overexpression in mouse ventricular myocytes. (A) Averaged peak current-voltage
relationships demonstrate significant increase of ICa,L density at multiple depolarizing pulses in NFTG and FTG compared with NTG cardiomyocytes.
The voltage protocol used to record ICa,L is shown in the inset. (B) Inactivation time constants (tfast and tslow) were determined from ICa,L traces
depolarized to +10 mV fitted by double exponential equation: Y=Ymin+ A16[12exp(2t/tfast)] + A26[12exp(2t/tslow)], where Y is the fraction of
recovery, A1 and A2 are the maximum values of the fast and slow component, and tfast and tslow are the time constants, respectively.
doi:10.1371/journal.pone.0004133.g002
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Changes in Ca
2+ release into and removal from the cytosol, as
observed in FTG, may result in contractile impairment. We first
determined the extent to which Indo-1 loading affects myocyte
contractile properties in both FTG and NTG cells. The contractile
characteristics, i.e., twitch amplitude, shortening velocity, and
relaxation time were severely distorted by Indo-1 in both groups of
cells; the buffering effect on twitch amplitude was greater in FTG
than in NTG myocytes (Table S2). To assess artifact-free
contraction characteristics, we performed additional studies in
non-Indo-1 loaded cells to analyze Ca
2+ buffering.
In response to the initial excitation following rest the absolute
contraction amplitude was greater in the NFTG than in FTG or
NTG (Figure 6A–C). As stimulation from rest continues, the
normal response is for contraction amplitude to decrease, as it does
in NTG. During stimulation at low rates (0.5–1 Hz), the relative
decline in NTG was greater than that in FTG or NFTG: the
absolute contraction amplitude in NFTG and FTG exceeds that in
NTG by 50%. This is consistent with a hypercontractile stage in
the evolution of cardiomyopathy in other models, including
humans [9]. Greater contraction amplitude in TG cells suggests a
relative inability to appropriately reduce the cell Ca
2+ load in this
context [1,10,11]. Contraction amplitude remained higher in
NFTG cells than in NTG cells during steady state stimulation at
2–4 Hz, but in FTG it dropped to that of NTG. Note that failure
of FTG to maintain augmented contraction amplitude vs. NTG,
or one equivalent to NFTG at the higher stimulation rates,
occurred in the context of a larger SR Ca
2+ release flux and Ca
2+
transient amplitude in FTG vs. NTG (Figure 4).
The absolute T50 of cell relengthening (relaxation), like that of
the Indo fluorescence transient (Figure 3), was prolonged in FTG
in the initial excitation following rest. But T50 of relaxation
converged toward other groups with increasing stimulation rates
(Figure 6D, E). The absolute cell length at rest remained constant
among the 3 groups (Figure 6F). Both transgenic groups showed
an inability to maintain a normal diastolic length as stimulation
frequency increased (Figure 6G). In FTG, this could result from an
inability to maintain a normal diastolic Ca
2+, reflected by failure to
maintain a normal diastolic Indo-1 fluorescence ratio (Figure 3E).
Thus, in myocytes from the NFTG hearts, electrical stimulation at
high rates uncovered a diastolic contractile failure: in the myocytes
from the grossly dilated hearts of congested FTG mice, high rates
Figure 4. Effect of caffeine on Ca
2+ transients. (A) Represents an average of the tracings of caffeine-induced Ca
2+ transients (20 mmol/L) prior
to and (B) after stimulation at 4 Hz and Indo-l loaded isolated cardiomyocytes from all three groups. (C) Comparison of average peak values of
caffeine-induced Ca
2+ transients or SR calcium load at rest and after 4 Hz stimulation. SR calcium load was significantly increased under both
protocols in FTG group. (D) Representative example of rapid application of caffeine to a cardiomyocyte.
doi:10.1371/journal.pone.0004133.g004
Figure 3. Changes in Ca
2+ transient and decline in response to an increase in frequency. (A) Original representative recording showing
Indo-1 fluorescence (410/490) transients in response to electrical stimulation following a two-minute rest and during steady state stimulation at 0.5 to
4 Hz in FTG. (B) Calcium transient amplitude, (C) maximal velocity of Ca
2+ transient upstroke, (D) time to 50% decay (T50) and (E) diastolic ratio in
Indo-1 loaded mouse ventricular cardiomyocytes. + ANOVA across all stimulation rates P,0.01 vs NTG
doi:10.1371/journal.pone.0004133.g003
HF SR Ca
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diastolic contractile failure. A ‘‘relative contractile, i.e., failure’’
also occurred within FTG at high stimulation rates, as the
reduction in contraction amplitude was not accompanied by a
reduction in Ca
2+ release following excitation (Figure 4B vs. 6B).
This could, in part, be due to a failure to maintain diastolic Ca
2+
levels, but cannot be attributed to a failure to release Ca
2+ into the
cytosol following excitation.
Expression of Ca
2+ cycling proteins
Quantitative Western Blot techniques comparing NFTG and
NTG (8–11 mo) showed: a 30% decrease in SERCA2a levels;
50% increase in NCX; 120% increase in PLNp (PLN pentamer)
and 73% and 54% decrease in its phosphorylation levels of PS16
and PT17, respectively normalized to total PLNp; by at 48%
decrease in RyR2 levels but 115% hyperphosphorylation of RyRs
at Ser2089 (Figure 7).
Western blot analysis comparing FTG and NTG (8–11 mo)
showed: an 80% decrease in the PLN monomer (PLNm); a 57%
decrease in the PLNp; a 36% decrease in PLN-PS16; a 60%
decrease in PLNp-PT17; a 5% decrease in SERCA2a; a 20%
increase in NCX; a 43% increase in PKCa; and surprisingly, a
70% decrease in RyR2 and 25% decrease in RyR2-PS2809
(Figure 8).
Discussion
There are several novel results of the present study. In NFTG at
8–11 mo of age, heart mass and average myocyte sizes are
increased by about 25% relative to age-matched NTG as is the
case in 4 mo a1CTG vs. NTG cells [4]. During the evolution from
NFTG to the FTG state, both heart mass and myocyte size are
increased markedly. At low rates of stimulation several other
features of 4 mo a1CTG myocytes, [4] including an increased
[Ca
2+]i transient elicited by electrical stimulation and a normal SR
Ca
2+ load, are retained in 9 mo NFTG. Cardiomyocytes from
both the NFTG and FTG myocytes at 8–11 mo showed a marked
increase in ICa,L amplitude compared to NTG. In FTG, in
contrast to NFTG, both, the Ca
2+ transient amplitude following
excitation and the SR Ca
2+ load are increased. While systolic Ca
2+
release in FTG is higher than in NFTG, and continues to be
elevated during stimulation over a wide range of rates,
mechanisms that regulate Ca
2+ removal from the cytosol are
further impaired, and diastolic [Ca
2+]i levels increase excessively
during stimulation at high frequencies, causing a more marked
impairment of diastolic myocyte length than observed in NFTG
(see below). Thus, although NCX function, as reflected in a
reduced T50 of the caffeine transient relaxation, is enhanced in
FTG, this is not sufficient to maintain a normal diastolic Ca
2+
during high rates of stimulation.
Figure 5. Changes in Ca
2+ transient kinetics in response to caffeine application. (A) Average caffeine-induced Indo-1 fluorescence Ca
2+
transient ratio (410/490), normalized to their peak amplitude at rest and (B) after stimulation at 4 Hz in all three groups. (C) Average T50 of the
normalized caffeine-induced Indo-1 fluorescent Ca
2+ transients in rest and after stimulation at 4 Hz.
doi:10.1371/journal.pone.0004133.g005
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previously measured. Over a wide range of stimulation rates, the
NFTG exhibit a hypercontractile state accompanied by diastolic
failure due to an inability to maintain normal diastolic length. But
in FTG, despite increased Ca
2+ transient amplitude, the
contraction amplitude across a broad range of stimulation rates
FTG is not greater than in NFTG. This indicates that a relative
systolic contractile failure has occurred with evolution from the
NFTG to FTG state. At high rates of stimulation, the contraction
amplitude of FTG declines below that of NFTG to the level in
NTG without a decline in SR Ca
2+ release and is accompanied by
marked diastolic abnormalities. Thus NFTG and FTG differ in
that the latter exhibit frank contractile systolic failure and more
severe Ca
2+ and contractile diastolic failure than do the former.
Diastolic abnormalities accompany hypercontractile function in
other animal experimental models [1]. The hypertrophic SHR
myocytes studied at 23uC present a markedly similar profile to
NFTG described herein [1,4,12]. In contrast, myocytes from some
other models of cardiac hypertrophy exhibit both reduced Ca
2+
transient and contraction amplitudes. A common clinical correlate
of NFTG may be hypertrophic non-dilated cardiomyopathy [13].
A hypercontractile state is attributable, at least in part, to an
increased cytosolic [Ca
2+]i transient following excitation and may
involve myofilaments, Ca
2+ energetic mechanisms, matrix prop-
erties or interactions of all.
It has recently been suggested that, like NFTG myocytes in the
present study, an abnormal frequency-dependent response of
human heart failure is a pathophysiologic signature of the
cardiomyopathic state [1,2]. Both the hypercontractile state of
NFTG myocytes, like the failing human heart, may reflect an
altered functional balance between Ca
2+ influx, reuptake and
extrusion from the cell [11] and can occur in the absence of
systolic failure [14]. In failing ventricular myocardium, the positive
FFR disappears and becomes flat or negative [1,2]. Multiple
alterations in Ca
2+ handling determine negative staircase in a
cellular heart failure model [15]. Interestingly, in the MLP
knockout mouse with dilated cardiomyopathy (enhanced basal
SERCA activity) increased PLN phosphorylation is believed to
limit FFR [16]. In human heart failure reduced expression of
SERCA has been demonstrated [1,2] however in animal studies,
there is less consistency [1]. PLN expression levels are, however
insufficient to evaluate the regulation of SERCA, as the level of
inhibition of SERCA by PLN depends on the degree of
phosphorylation. A decrease in the level of PLN phosphorylation
at Ser16 (mainly affected by PKA activity) has been reported in
some papers in heart failure, as against decreased levels of Thr17
phosphorylation (affected by the decreased CaMKII activity)[2].
Our results show that the maintenance of a normal myocyte SR
Ca
2+ load afforded to older NFTG mice fails as the dilated,
congested cardiomyopathic state evolves. In marked contrast to
Figure 7. A comparison of Ca
2+ cycling protein levels in NTG vs. NFTG measured by Western blot analysis. (A) Representative Western
blots in NTG and NFTG hearts. (B) Column diagram of average protein levels. All samples were done in duplicates; n=4–8; *P,0.05 by Student’s t-
test.
doi:10.1371/journal.pone.0004133.g007
Figure 6. Contractile parameters of isolated ventricular myocytes from NTG, NFTG and FTG hearts. (A) Representative example of the
negative staircase of twitch contractions following rest during stimulation at 0.5 Hz and during steady state stimulation at 0.5–4 Hz in FTG. (B–G)
Average contraction characteristics in response to electrical stimulation following rest and during steady state stimulation at varying frequencies. (B)
Figure illustrates absolute data in non-Indo-1 AM-loaded, isolated cardiomyocytes, (G,F) are expressed as percentage change from 0.5 Hz values in
(C,E and G). (B,C) Show contraction amplitude (or Twitch Amplitude). (D,E) Illustrate changes in the maximal rate of contraction. (F,G) Depict
diastolic cardiomyocyte length. * All 3 groups differ from each other, ANOVA P,0.03; + FTG interaction with NTG and NFTG, ANOVA P,0.01.
doi:10.1371/journal.pone.0004133.g006
HF SR Ca
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2+ tran-
sient amplitude of FTG is increased. Also in contrast to most other
experimental cardiomyopathies, (calcineurin overexpressing mice
being an exception [17] in which the SR Ca
2+ load decreases)
(Table S3), the SR Ca
2+ load of FTG increases, and, following
excitation, generates a Ca
2+ transient of increased amplitude.
Since neither ICa,L amplitude nor inactivation under VC did differ
between FTG and NTG, the source of the increased Ca
2+ that
likely augments the SR Ca
2+ load in FTG compared to NFTG
cannot be ascertained with certainty, particularly in the absence of
action potential data in these two groups. Potential other sources
of ‘‘extra’’ Ca
2+ in FTG mice may be increased influx via NCX
[1,3,4,10] or efflux from mitochondria [18].
It is perplexing that the SR Ca
2+ load increases during the
evolution from NFTG to FTG, since ICa,L density does not
increase, and Ca
2+ efflux via NCX is augmented, it might be
expected that mechanisms to reduce Ca
2+ pumping into the SR
might prevail: in many other HF models, SERCA2a becomes
reduced, PLN increases, and its phosphorylation decreases [1,7].
The increased SR Ca
2+ load in FTG is apparently linked to an
increased Ca
2+ availability for SR pumping, as evidenced by an
increase in diastolic Indo-1 fluorescence during pacing. The latter
may also reflect an increase in the net cell Ca
2+ load between the
NFTG and FTG states.
Alterations in RyR [1] might also contribute to an increased RyR
Ca
2+ leak. Unlike some other heart failure models, RyR2 and RyR2-
P decrease, in the FTG (c.f., Table S3 Online Supplement),
another conundrum. Some reports suggest that PKA phosphoryla-
tion of RyR2 has little functional relevance for diastolic Ca
2+releaseif
SR Ca
2+ levels remain constant [1,2]. Marks and coworkers in many
studies and perspectives, indict RyR2 and Ca
2+ leak as causal of
arrhythmias and sensitivities to heart failure [2,19,20]. There is a
great deal of controversy surrounding the significance of both the
increased Ca
2+ l e a kt h e o r y ,a sw e l la st h ed e c r e a s e dS RC a
2+ content
concept, as some studies have not been confirmed by others [1,2,21].
Our results, in fact, demonstrate that frank heart failure [10,11] can
occur in the context of reduced total RyR2, phosphorylated RyR2
at Serine 2809 and increased SR Ca
2+ loading [22,23]. This
underscores the complexity of ‘‘heart failure’’, and the caution that
should be applied to any specific molecular conclusion at this point.
Some might argue that the FTG in which SR Ca
2+ remains
elevated does not represent a ‘‘good’’ model of heart failure. But
what, then, is a ‘‘good model’’ of heart failure? A ‘‘good model’’ of
heart failure should represent what happens in the human condition.
Figure 8. Western blot analysis of Ca
2+ regulatory proteins in FTG and NTG hearts. (A) Representative Western blots of Ca
2+ regulatory
proteins from NTG and FTG. (B) Analysis of calcium regulatory protein abundance normalized to actin. All samples were done in duplicates; n=4–6;
*P,0.05 and **P,0.001 by Student’s t-test.
doi:10.1371/journal.pone.0004133.g008
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2+ load in end
stage human HF is central to contractile dysfunction of human
cardiomyocytes [10]. However, not all studies in human HF share
this view [24]. In fresh, end stage failing hearts (a large number)
obtained at transplant, using two different procedures, SR Ca
2+
accumulation demonstrated slow uptake kinetics and a complete lack
of Ca
2+ release compared to non-failing samples, in which Ca
2+
release was vigorous [25,26]. These results, repeated on any human
hearts are consistent with the present findings in the FTG myocytes.
Further, a window of enhanced contractility, depending upon the
stimulation rate, has been observed in human HF [1]. However, even
in HF models that exhibit a reduced SR Ca
2+ load, muscles or
myocytes under study conditions that have been employed exhibit an
increase in the diastolic Ca
2+ at higher pacing rates i.e. similar
patterns observed in the present study in FTG.
A recent study on failing human and mouse frank heart failure
[27] has discovered a heretofore unrecognized gain of function
change in the L-type Ca
2+ channel. Channel availability and single
channel activity were markedly altered, the culprit being an up
regulation of the b2-subunit of the L-VDCC complex. Further, the
ensemble single channel activities of the terminally failing mouse
heart and human heart were identical. Thus, quantitative
measurements of single L-type channel function are vital when
considering mechanisms involved in frank heart failure in all
models of HF, regardless of species.
Other possible mechanisms in the conundrum of the end stage
HF phenotype include heart rate responses [10], diminished
contractile performance [28], increased diastolic calcium [29].
Abnormal myofilament mechanisms [30] may explain, in part, the
deficient myocardial function of the intact a1CTG, heart [4] but
the mechanistic link between the two is not firm, because isolated
cells, e.g., those analyzed in the present study, have no preload or
afterload, two factors that, not only regulate contraction, but also
regulate myofilament Ca
2+ binding and release characteristics. It is
noteworthy, though, that regardless of the SR Ca
2+ load,
contractile failure in cells or muscles from end stage, dilated heart
failure hearts is exacerbated with increasing pacing rates in
virtually all studies employing different pacing rates [10,11,14].
Myofilament abnormalities other than Ca
2+ binding or energetic
fatigue, especially the activity of the b2-subunit of the L-VDCC,
should continue to be recognized as mechanisms that underlie HF
[10]. PKCa dephosphorylation of PLN was paralleled by
diminished peak calcium transients.
Heart remodeling (dilatation), itself, leads to increased afterload,
fibrosis, myofilament disarray and increased cell death [10], and
each of these have been implicated in contractile dysfunction
characteristic of FTG mice [4]. We observed that the ratio of
TUNEL-positive cardiomyocytes to the total cardiomyocytes was
higher in NFTG and FTG without signs of HF compared to
littermate NTG (data not shown).
Of possiblerelevanceto thea1C-TGmodel,overexpressionofthe
b2a subunit of the L-VDCC leads to enhanced ICa,L resulting in
Ca
2+ dependent apoptosis in adult myocytes [18,31] consistent with
recent findings [27]. Studies of the transition from hypertrophy to
HF that occurs in SHR during advanced age [32] have also shown
that increased cardiomyocyte apoptosis occurs [33].
To summarize, end stage cardiac failure phenotype is remarkably
similarto that in other typesof heart failure in which myocytes have a
reduced SR Ca
2+ load and reduced Ca
2+ amplitude, at least under
conditions that have been employed in these studies (Table S1).
Similar heart failure phenotypes are associated with both an
increased or decreased SR Ca
2+ load as well as SR Ca
2+ release
following excitation. This suggests that there is a requirement for
optimal Ca
2+ transient amplitude to prevent HF, or that the mode of
measurements, type of failure and how quickly measurements are
made are of significance. Heterogeneity of Ca
2+ release within and
among cells in intact myocardium impairs both systolic and diastolic
function and provokes arrhythmias [34]. Recent studies have indeed
begun to address this issue in experimental heart failure models
[2,4,7,35,36].
Materials and Methods
FBV/n in-house bred 8–11 mo old a1CTG mice and their wild-
type (NTG) littermates of the same age were used in all of the
experiments. The animal protocols used in these studies were
approved by the Animal Care Committees of each institution
involved. At 9 mo of age some a1CTG mice begin to manifest a
dilated cardiomyopathy with markedly impaired contractile
function in vivo [4]. Upon sacrifice we observed a1CTG -mice
at this age exhibited two phenotypes: the absence of gross cardiac
dilatation and congestion, evidenced by the absence of pericardial
and pleural effusions and atrial thrombi (n=4), and gross cardiac
dilatation with both pericardial and pleural effusions and left atrial
thrombi (n=4). We designated these two groups of mice at
sacrifice as non-failing a1CTG (NFTG) and failing a1CTG (FTG),
respectively, and structured our data analysis to compare some
aspects of Ca
2+ regulation and contraction characteristics of
myocytes isolated from these hearts.
We measured Ca
2+ transients in Indo-1-AM loaded myocytes at
frequencies of stimulation ranging from 0.5–4 Hz. The same
stimulation protocol was used to measure myocyte mechanics in
both Indo-1-loaded and unloaded cells. The SR Ca
2+ load was
determined measuring caffeine induced Ca
2+ transients in Indo-1-
AM loaded cells. Inward Ca
2+ current through the L-type channel
was measured under step-voltage protocols. We carried out
quantitative and traditional Western blotting for the Ca
2+
handling proteins. FTG and NFTG subgroup comparisons were
stratified prospectively and investigators were blinded when doing
their experiments. All methods have been previously published
and are detailed in the Methods S1.
Statistics
Results are reported as mean 6SEM. Differences among NTG
and NFTG and FTG cells were compared by ANOVA. A value of
p,0.05 was considered significant.
Supporting Information
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